Annual Conference

The 2023 NCCN Annual Conference was held Friday, March 31 – Sunday, April 2, 2023, at the Orlando World Center Marriott and virtually.

View Press Coverage

Save the dates!

NCCN 2024 Annual Conference
Orlando World Center Marriott • Orlando, FL
Friday, April 5, 2024 – Sunday, April 7, 2024

Continuing Education

Conference attendees will have the opportunity to view conference sessions on-demand in the Virtual Event Platform through May 2023. Recorded presentations will be available on the NCCN Continuing Educational Portal,, in June 2023.

Experts from leading cancer centers came together to discuss updates to NCCN Guidelines®, the latest advances across several cancer types, and emerging issues in oncology.

CE credit was available for the oncology team. There were more than 30 live and on-demand educational sessions!

The agenda covered updates across a wide range of cancers including:

  • Bladder Cancer
  • Breast Cancer
  • Central Nervous System Cancers
  • Colorectal Cancer
  • Hepatobiliary Cancers
  • Multiple Myeloma
  • Non-Small Cell Lung Cancer
  • Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
  • Prostate Cancer
  • Rectal Cancer
  • Renal Cell Carcinoma

Other sessions focused on issues in oncology and patient care:

  • Health Needs of the LGBTQ+ Community
  • Health System Recruitment and Retention
  • New Patient Access Programs
  • Patient Reported Outcomes
  • Reducing Admissions and Readmissions
  • Screening in Underrepresented Populations
  • Sexual Identity and Function
  • Sleep Disorder, Fatigue, and Cognitive Function
  • Social Determinants of Health

This activity is supported by educational grants from:

  • Astellas and Seagen
  • AstraZeneca
  • AVEO Pharmaceuticals, Inc. (“AVEO Oncology”)
  • BeiGene
  • Coherus BioSciences
  • Eisai
  • Exact Sciences
  • Fresenius Kabi USA, LLC
  • Genentech, a member of the Roche Group
  • GSK
  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Lantheus
  • Lilly
  • Novartis
  • Olympus Corporation of the Americas
  • Puma Biotechnology
  • TerSera Therapeutics LLC.


This activity is supported by independent educational grants from:

  • AbbVie
  • Daiichi Sankyo
  • Gilead Sciences, Inc.
  • Incyte Corporation

This activity is supported by medical education grants from:

  • Exelixis, Inc.
  • Karyopharm Therapeutics

This project has been made possible in part by a grant from:

  • Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

This activity has been supported by an unrestricted educational grant from:

  • GE HealthCare, Pharmaceutical Diagnostics

This activity is supported by educational funding provided by:

  • Amgen

This activity is supported through an independent medical education grant from:

  • Merck & Co., Inc.

Supported by a grant from:

  • Pfizer Inc.



Exhibit Hall

The NCCN Exhibition Hall was held in-person and virtually for networking opportunities and to gather the latest information from industry-sponsored exhibits and more.

View Exhibit Guide


For exhibitor opportunities, contact Jennifer Tredwell, Vice President, NCCN Marketing and Communications.